Company / Debt per Share
Tarsus Pharmaceuticals, Inc. Debt per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.89
FY2025
5-year range
$0.00 / $2.10
FY2021-FY2025
Trend
-10.1%
vs FY2024
Sector context
#43 of 82
Health Care
What the data says
At $1.89, Tarsus Pharmaceuticals, Inc.'s debt per share ranks #40 of 82 in the Health Care sector. Increased from $1.12 to $1.89 over the past 2 years.
Based on SEC 10-K filings.
1.89 in FY2025 with a 3-year CAGR of +26.2%.
Increased from $1.12 to $1.89 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +26.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#40 of 82 in Health CareTop 48% of 82This company $1.89 Sector average $151.59
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 10.1% year-over-year.
- Ranks #43 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2024.
- Lowest debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.89 | -10.1% |
| FY2024 | $2.10 | +88.0% |
| FY2023 | $1.12 | +18.9% |
| FY2022 | $0.94 | - |
| FY2021 | $0.00 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026